DK3431460T3 - Ny formulering og fremgangsmåde til syntese - Google Patents
Ny formulering og fremgangsmåde til syntese Download PDFInfo
- Publication number
- DK3431460T3 DK3431460T3 DK18187551.9T DK18187551T DK3431460T3 DK 3431460 T3 DK3431460 T3 DK 3431460T3 DK 18187551 T DK18187551 T DK 18187551T DK 3431460 T3 DK3431460 T3 DK 3431460T3
- Authority
- DK
- Denmark
- Prior art keywords
- synthesis
- procedure
- new formulation
- formulation
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1411569.5A GB201411569D0 (en) | 2014-06-30 | 2014-06-30 | Novel formulation and method of synthesis |
| EP15732267.8A EP3160923B1 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3431460T3 true DK3431460T3 (da) | 2021-05-10 |
Family
ID=51410328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18187551.9T DK3431460T3 (da) | 2014-06-30 | 2015-06-30 | Ny formulering og fremgangsmåde til syntese |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11077216B2 (da) |
| EP (2) | EP3431460B1 (da) |
| JP (3) | JP6997519B2 (da) |
| KR (1) | KR102381616B1 (da) |
| CN (1) | CN106458785B (da) |
| AU (1) | AU2015283054B2 (da) |
| BR (1) | BR112016030350B1 (da) |
| CA (1) | CA2953641C (da) |
| DK (1) | DK3431460T3 (da) |
| ES (1) | ES2710073T3 (da) |
| GB (1) | GB201411569D0 (da) |
| IL (1) | IL249348A0 (da) |
| PL (1) | PL3160923T3 (da) |
| PT (1) | PT3160923T (da) |
| RU (1) | RU2016147507A (da) |
| SG (1) | SG11201610883QA (da) |
| TR (1) | TR201901460T4 (da) |
| WO (1) | WO2016001199A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220001034A1 (en) * | 2014-06-30 | 2022-01-06 | Ge Healthcare Limited | Novel formulation and method of synthesis |
| US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
| US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1356827A1 (en) | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
| US7993626B2 (en) | 2007-01-11 | 2011-08-09 | Immunomedics, Inc. | Methods and compositions for F-18 labeling of proteins, peptides and other molecules |
| CA2783275A1 (en) | 2003-07-24 | 2005-02-03 | Bracco Imaging S.P.A. | Stable radiopharmaceutical compositions and methods for their preparation |
| GB0422004D0 (en) | 2004-10-05 | 2004-11-03 | Amersham Plc | Method of deprotection |
| EP1893246A4 (en) | 2005-06-23 | 2009-05-06 | Univ Emory | STEREOSELECTIVE SYNTHESIS OF AMINO ACID ANALOGUE FOR TUMOR IMAGING |
| KR20080071146A (ko) | 2005-11-29 | 2008-08-01 | 니혼 메디피직스 가부시키가이샤 | 방사성 할로겐 표식 유기 화합물의 전구체 화합물 |
| CA2651786C (en) | 2006-05-11 | 2014-11-04 | Nihon Medi-Physics Co., Ltd. | Process for production of radioactive fluorine-labeled organic compound |
| PL2106808T3 (pl) | 2006-12-21 | 2018-07-31 | Nihon Medi-Physics Co., Ltd. | Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy |
| CN101636183B (zh) | 2007-02-13 | 2014-03-19 | 日本医事物理股份有限公司 | 放射性诊断显像剂的制备方法 |
| CN108218650A (zh) | 2010-12-29 | 2018-06-29 | 通用电气健康护理有限公司 | 洗脱溶液 |
| EP2793954B1 (en) * | 2011-12-21 | 2020-10-21 | GE Healthcare Limited | 18f-fluciclovine compositions in citrate buffers |
| GB201117785D0 (en) | 2011-10-14 | 2011-11-30 | Ge Healthcare Ltd | Improved radiosynthesis method |
| GB201205703D0 (en) | 2012-03-30 | 2012-05-16 | Ge Healthcare Ltd | Synthon composition |
| GB201214220D0 (en) | 2012-08-09 | 2012-09-19 | Ge Healthcare Ltd | Radiosynthesis |
-
2014
- 2014-06-30 GB GBGB1411569.5A patent/GB201411569D0/en not_active Ceased
-
2015
- 2015-06-30 BR BR112016030350-4A patent/BR112016030350B1/pt active IP Right Grant
- 2015-06-30 SG SG11201610883QA patent/SG11201610883QA/en unknown
- 2015-06-30 EP EP18187551.9A patent/EP3431460B1/en active Active
- 2015-06-30 JP JP2016573925A patent/JP6997519B2/ja active Active
- 2015-06-30 US US15/318,599 patent/US11077216B2/en active Active
- 2015-06-30 RU RU2016147507A patent/RU2016147507A/ru unknown
- 2015-06-30 DK DK18187551.9T patent/DK3431460T3/da active
- 2015-06-30 EP EP15732267.8A patent/EP3160923B1/en active Active
- 2015-06-30 TR TR2019/01460T patent/TR201901460T4/tr unknown
- 2015-06-30 PT PT15732267T patent/PT3160923T/pt unknown
- 2015-06-30 CN CN201580035646.6A patent/CN106458785B/zh active Active
- 2015-06-30 AU AU2015283054A patent/AU2015283054B2/en active Active
- 2015-06-30 CA CA2953641A patent/CA2953641C/en active Active
- 2015-06-30 ES ES15732267T patent/ES2710073T3/es active Active
- 2015-06-30 KR KR1020167036497A patent/KR102381616B1/ko active IP Right Grant
- 2015-06-30 PL PL15732267T patent/PL3160923T3/pl unknown
- 2015-06-30 WO PCT/EP2015/064796 patent/WO2016001199A1/en active Application Filing
-
2016
- 2016-12-01 IL IL249348A patent/IL249348A0/en active IP Right Grant
-
2020
- 2020-07-02 JP JP2020114659A patent/JP2020172518A/ja active Pending
-
2022
- 2022-06-13 JP JP2022095283A patent/JP2022136074A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017520550A (ja) | 2017-07-27 |
| EP3431460A3 (en) | 2019-02-20 |
| WO2016001199A1 (en) | 2016-01-07 |
| TR201901460T4 (tr) | 2019-02-21 |
| CA2953641A1 (en) | 2016-01-07 |
| EP3431460B1 (en) | 2021-02-17 |
| JP2022136074A (ja) | 2022-09-15 |
| AU2015283054A1 (en) | 2016-12-08 |
| JP6997519B2 (ja) | 2022-02-04 |
| US11077216B2 (en) | 2021-08-03 |
| EP3160923B1 (en) | 2019-01-02 |
| BR112016030350A2 (da) | 2017-08-22 |
| KR102381616B1 (ko) | 2022-04-01 |
| AU2015283054B2 (en) | 2017-11-23 |
| JP2020172518A (ja) | 2020-10-22 |
| GB201411569D0 (en) | 2014-08-13 |
| KR20170027732A (ko) | 2017-03-10 |
| PT3160923T (pt) | 2019-02-12 |
| US20170128597A1 (en) | 2017-05-11 |
| RU2016147507A3 (da) | 2019-01-18 |
| EP3160923A1 (en) | 2017-05-03 |
| CN106458785A (zh) | 2017-02-22 |
| EP3431460A2 (en) | 2019-01-23 |
| RU2016147507A (ru) | 2018-07-30 |
| CN106458785B (zh) | 2020-10-09 |
| SG11201610883QA (en) | 2017-01-27 |
| ES2710073T3 (es) | 2019-04-22 |
| BR112016030350B1 (pt) | 2024-01-30 |
| IL249348A0 (en) | 2017-02-28 |
| NZ727574A (en) | 2023-11-24 |
| CA2953641C (en) | 2022-09-13 |
| PL3160923T3 (pl) | 2019-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| DK3200615T3 (da) | Kaloriefrie sødestoffer og fremgangsmåder til syntetisering | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3125927T3 (da) | Fremgangsmåder og sammensætninger til immunmodulering | |
| DK3092256T3 (da) | Forbindelser og sammensætninger til immunterapi | |
| DK3224603T3 (da) | Nordning og fremgangsmåde til materialekarakteristik | |
| DK3227336T3 (da) | Anti-CD79b-antistoffer og fremgangsmåder til anvendelse | |
| DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
| DK3212189T3 (da) | Substituerede chromaner og fremgangsmåde til anvendelse deraf | |
| DK3210977T3 (da) | Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf | |
| DK2949365T3 (da) | Gåtræningsapparat og gåtræningsfremgangsmåde deraf | |
| DK3137605T3 (da) | Sammensætninger og fremgangsmåder til modulering af angiopoietin-lignende-3-ekspression | |
| DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| BR112016030697A2 (pt) | inibidores da desmetilase-1 específica da lisina | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| DK3015526T3 (da) | Hydrofluorolefinbaseret sammensætning og anvendelse deraf | |
| DK3116911T3 (da) | Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse | |
| DK3230795T3 (da) | Prægelak og fremgangsmåde til prægning | |
| DK3102189T3 (da) | Sammensætning og fremgangsmåde til at fremme søvn | |
| DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3134061T3 (da) | Peroxidformuleringer og fremgangsmåder og applikatorer til anvendelse heraf |